The Catalan Government has agreed today to the implementation of the José Carreras Research Institute
- The José Carreras Research Institute against Leukaemia, will be administered by a newly created Foundation of the Catalan Government and the Private José Carreras International Foundation.
- The aim is to make this Institute a leading centre on a global scale for biomedical research in the field of hematological malignancies, and especially leukaemia.
- This centre will be the first of its kind in Spain to specifically investigate hematological malignancies and one of only a few globally.
- The Institute will have two campuses; one close to the Hospital Universitario Germans Trias i Pujol (spanish) in Badalona and another campus in the Hospital Clínic (spanish) in Barcelona.
The Catalan government has agreed today to the implementation of the new José Carreras Research Institute against Leukaemia. The main aims of the new Institute are to promote the biomedical research of hematological malignancies, especially leukaemia, and also to develop preventative and personalized medicines in the same field.
The centre is a joint partnership between the government and the José Carreras International Foundation against Leukaemia. The tenor, José Carreras established the Foundation on the 14th of April 1988 to fight against leukaemia.
José Montilla y José Carreras during the agreement of intentions that both bodies signed in April 2009. (Photo: Rubén Moreno)
It is the goal of the government and the José Carreras Foundation to create an Institute that will be a centre of reference on a worldwide scale, in the field of hematological malignancies, especially leukaemia.
The new facility will take another step towards the realization of quality biomedical research, which forms a part of the government's commitment to healthcare, in addition to the fight against cancer and hematological malignancies, which form one of the largest groups of diseases which cause of mortality.
The José Carreras Foundation against Leukaemia has dedicated more than 20 years to scientific research.
The new Institute will be situated in two campuses: a brand new building in the campus of the Hospital Universitario Germans Trias I Pujol in Badalona and the other in the surroundings of the Hospital Clínic in Barcelona. The superb location of the Germans Trias I Pujol campus, next to the Germans Trias I Pujol Institute of Sanitary Research and other research centres such as the IMPPCC (Personalized and Preventative Medicine Institute against Cancer), will facilitate the research and enhance quantity new knowledge we can obtain regarding improvements in clinical practice, and the prevention, diagnosis and treatment of hematological malignancies.